October glows pink each year, a vibrant reminder of the global fight against breast cancer.

As we mark Breast Cancer Awareness Month in 2026, the numbers underscore both the scale of the challenge and the power of collective action. According to the World Health Organization and the International Agency for Research on Cancer, breast cancer remains the most common cancer among women worldwide. Recent estimates indicate around 2.4 million new cases and nearly 694,000 deaths globally in recent data years, with 8.2 million women living with the disease at the end of 2024. This means that one in 20 women faces a lifetime diagnosis risk based on current rates.

Yet let this month be the one of hope grounded in evidence: when detected early, breast cancer is highly curable, with five-year survival rates near 100% for disease confined to the breast compared to much lower figures once it has spread to distant organs. We know that early detection through timely screening and diagnostics can prevent progression, spare women aggressive treatments, and save lives on a massive scale. The WHO’s Global Breast Cancer Initiative aims to reduce mortality by 2.5% annually, potentially averting 2.5 million deaths by 2040 through better access to care.

This topic is deeply personal to me and brings a long-lasting passion. Breast cancer, and cancer more broadly, has always been close to my heart. It is the reason I pursued biomedical engineering and focused my PhD on optical tomography for breast cancer detection.

My goal was to create a compact, portable device that could deliver accessible scanning in the most remote regions, from rural Africa to underserved communities everywhere. Pink October offers a platform to amplify what matters most: knowledge, access, and support that can reach every woman, regardless of where she lives.

Early detection- an opportunity to save lives

Early detection does not prevent cancer from starting, but it creates an opportunity to treat disease before it spreads. Mammography screening has been shown to reduce breast cancer deaths. When caught at an early stage, treatment is often less invasive, with excellent outcomes. Delaying diagnosis until later stages not only worsens survival but increases the physical, emotional, and financial burden. Screening programs worldwide have demonstrated mortality reductions of up to 40% in some populations through consistent access. When detection is followed by timely and effective treatment: WHO reports expected five-year survival of around 41% in low-income countries versus 87% in high-income countries. Closing that gap requires affordable imaging, reliable testing, treatment, and continuing support.

Younger women cannot be overlooked

Incidence rates are rising among younger women in many regions, particularly across Asia. A 2025 analysis showed that breast cancer incidence among women aged 15–39 rose in all 11 Southeast Asian countries between 1990 and 2021, with notable annual increases in Thailand (about 4%) and Vietnam (about 3%). Thailand’s rate reached 11.78 cases per 100,000 women in this age group in 2021. In India, incidence has roughly doubled over three decades, with a pronounced surge in younger, pre-menopausal patients. Standard screening guidelines often start at 40 or 50, but heightened vigilance, including clinical breast exams and risk assessment, is vital for younger demographics.

Choose the right tests

Mammography remains the standard screening tool for most women of appropriate age, often complemented by ultrasound for denser breasts or further evaluation. For those with a family history, genetic testing for BRCA1, BRCA2, and other mutations provides critical risk information, enabling personalized surveillance or preventive strategies. Recommendations differ by country; in the United States, guidelines recommend mammograms every two years from ages 40 to 74 for women at average risk. High-risk individuals may need earlier or additional testing. A new lump, nipple discharge, or skin change needs assessment at any age. Suspicious findings may require a biopsy to confirm the diagnosis.

Innovative supportive technologies

New technologies are making diagnosis more accurate and accessible. Clinicians can combine mammography, ultrasound, and MRI when appropriate. AI tools, such as Hera-MI’s Breast-SlimView, assist radiologists in reading images and provide a clearer view. Emerging blood-based tests and biomarker panels offer promising non-invasive options for initial risk assessment or monitoring, potentially guiding whether more invasive procedures are needed.

These advances mean doctors can better understand if cancer is present and what type it is. Treatments are increasingly personalized—different subtypes respond best to tailored therapies, including targeted drugs and immunotherapy. These developments bring real hope, but they work best alongside standard care and timely follow-up.

Healthy living, a chance to be cancer free

Breast cancer develops through complex interactions involving ageing, inherited biology, hormonal factors, and other influences. Many patients have no knowledge of their family history. Healthy habits can lower risk for several cancers but cannot eliminate it. A diagnosis is never evidence of personal misalignment. Practical priorities include avoiding tobacco, limiting alcohol, eating a balanced diet rich in fruits, vegetables, and whole foods, maintaining a healthy weight, and aiming for at least 150 minutes of moderate activity weekly plus strength training twice a week.

Most adults need seven to nine hours of quality sleep nightly with a consistent schedule. Cultivating strong psychological and social support networks also builds resilience. A balanced lifestyle helps support overall well-being and can enable us to live longer, healthier and happier.

Support the person, not just the disease

The journey often involves surgery, chemotherapy, radiotherapy, and their side effects, such as fatigue or changes in body image. Anxiety and depression deserve attention too. Mental health resources are essential. Platforms and organizations dedicated to holistic care make a difference.

Sukuun.ai provides culturally sensitive support and resources globally. Other valuable tools include OWise for symptom tracking and wellbeing, Belong.Life for online patient communities and expert discussions, and telehealth counselling that brings psychological support into patients’ homes. These address the full spectrum of needs—from practical navigation of care to emotional resilience. Support can also be wonderfully ordinary: accompanying someone to appointments, preparing meals, or simply listening.

A commitment beyond October

Breast cancer affects women and, in smaller numbers (0.5–1%), men, across all ages and backgrounds. Men should also stay informed about their own health and support loved ones. Every patient is someone’s mother, daughter, sister, or friend. It is truly crucial to bring an ongoing attention to health, including regular check-ups and self-advocacy. New technologies continue to expand possibilities for earlier intervention and better quality of life.

As Pink October unfolds, let us celebrate progress while recommitting to action. Schedule that mammogram or discuss risk with your doctor. Encourage the women in your life to prioritize their health. Support research, equitable access, and compassionate care. Health is our most valuable asset so nurture it with intention, every month of the year.

About the Author:

Dr. KaT Zarychta is CEO of KaTFenix and Acceler8 Nexus, a healthcare innovation leader and strategic advisor with expertise in global health, emerging technologies, and patient advocacy. A PhD graduate in Laser Physics, she advises international institutions and champions inclusive, human centred approaches to healthcare innovation.

References:

WHO. (2025, August 14). Breast cancer. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/breast-cancer

National Breast Cancer Foundation. (2019). Early Detection. National Breast Cancer Foundation. https://www.nationalbreastcancer.org/early-detection-of-breast-cancer/

World Health Organisation. (2023). The Global Breast Cancer Initiative. Www.Who.Int. https://www.who.int/initiatives/global-breast-cancer-initiative

World Health Organization: WHO. (2026, July 8). First global breast cancer survival estimates show wide regional and income disparities. Who.Int; World Health Organization: WHO. https://www.who.int/news/item/08-07-2026-first-global-breast-cancer-survival-estimates-show-wide-regional-and-income-disparities

Chen, J., Ho, F. D. V., Feliciano, E. J. G., Wu, J. F., Magsanoc-Alikpala, K., & Dee, E. C. (2025). Trends in female breast cancer among adolescent and young adults in Southeast Asia. The Lancet Regional Health - Southeast Asia, 34, 100545. https://doi.org/10.1016/j.lansea.2025.100545

Cleveland Clinic. (2022, April 5). Mammogram: What Is It, Types, Prep & Results. Cleveland Clinic. https://my.clevelandclinic.org/health/diagnostics/4877-mammogram

Ren, W., Chen, M., Qiao, Y., & Zhao, F. (2022). Global guidelines for breast cancer screening: A systematic review. The Breast, 64(64), 85–99. https://doi.org/10.1016/j.breast.2022.04.003